These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 63273)

  • 41. F1 resistance to AKR lymphoma cells in vivo and in vitro.
    Schmitt-Verhulst A-M ; Zatz MM
    J Immunol; 1977 Jan; 118(1):330-3. PubMed ID: 830755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor cell-related syngeneic skin graft rejection in gross leukemia.
    Mariani T; Maruyama Y; Good RA
    Natl Cancer Inst Monogr; 1972 Dec; 35():309-20. PubMed ID: 4572830
    [No Abstract]   [Full Text] [Related]  

  • 43. Tumor growth in allogeneic mice bearing a lucite cylinder.
    Saal F; Colmerauer ME; Braylan RC; Pasqualini CD
    J Natl Cancer Inst; 1972 Aug; 49(2):451-8. PubMed ID: 5076826
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of a Moloney lymphoma with cyclophosphamide and H-2-incompatible spleen cells.
    Fefer A
    Cancer Res; 1973 Apr; 33(4):641-4. PubMed ID: 4696464
    [No Abstract]   [Full Text] [Related]  

  • 45. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
    Isakov N; Feldman M; Segal S
    Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new model of active specific immunotherapy using interleukin-1 and sonicated tumor supernatant in murine tumor system.
    Moriguchi Y; Kan N; Okino T; Harada T; Yamasaki S; Ichinose Y; Li L; Sugie T; Imamura M
    J Surg Oncol; 1996 Jun; 62(2):78-85. PubMed ID: 8649045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Host endocrine responses during tumor growth.
    Besedovsky H; del Rey A; Normann SJ
    Prog Clin Biol Res; 1989; 288():203-13. PubMed ID: 2654951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 50. Serological studies in mice bearing an allogeneic tumor.
    Davel L; Salmerón MY; Braun M; Pasqualini CD
    Cell Mol Biol Incl Cyto Enzymol; 1980; 26(2):197-200. PubMed ID: 7008943
    [No Abstract]   [Full Text] [Related]  

  • 51. Antibodies against a tumour-associated antigen in an AKR lymphoma conditioned to grow in BALB/c mice.
    Hajos SE; Alvarez E; Pierangeli S; Pasqualini CD; Margni RA
    Vet Immunol Immunopathol; 1984 Aug; 7(1):53-63. PubMed ID: 6485248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic allogeneic disease. II. Development of lymphomas.
    Armstrong MY; Gleichmann E; Gleichmann H; Beldotti L; Andre-Schwartz J; Schwartz RS
    J Exp Med; 1970 Sep; 132(3):417-39. PubMed ID: 5523966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allogeneic inhibition of transplanted tumor cells.
    Hellström KE; Hellström I
    Prog Exp Tumor Res; 1967; 9():40-76. PubMed ID: 4863163
    [No Abstract]   [Full Text] [Related]  

  • 54. Increased humoral and cellular immunity in mice inoculated with allogeneic tumor cells attached to microcarrier beads.
    Yefenof E; Schwartz S; Katz-Gross A
    Immunol Lett; 1983 Jan; 6(1):39-43. PubMed ID: 6840814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection against transplanted and spontaneous lymphoma by inoculation of heat-altered syngeneic tumor cells in splenectomized mice.
    Check JH; Brady LW; Leipold PL; O'Neill EA
    Cancer; 1974 Jul; 34(1):197-203. PubMed ID: 4834179
    [No Abstract]   [Full Text] [Related]  

  • 56. Normal murine endogenous lymphoid factor(s) inhibiting lymphocyte functions. I. In vivo effect on allogeneic tumor growth.
    Fejes M; Pasqualini CD; Braun M
    Oncology; 1980; 37(2):96-100. PubMed ID: 6444707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transfer of resistance against a transplantable BALB/c lymphoma.
    Wedderburn N; Campa M; Carter RL
    Eur J Cancer (1965); 1980 Mar; 16(3):375-81. PubMed ID: 7371691
    [No Abstract]   [Full Text] [Related]  

  • 58. Murine lymphoma-induced immunosuppression: requirement for direct tumour cell contact.
    Cimprich RS; Specter S; Friedman H
    Science; 1978 Apr; 200(4337):60-1. PubMed ID: 635572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Murine leukemia growth inhibition or enhancement following immunization with tumor cells antigenically altered by drug treatment.
    Riccardi C; Giampietri A; Puccetti P; Biancifiori F; Fioretti MC
    Pharmacol Res Commun; 1977 Apr; 9(4):349-58. PubMed ID: 141049
    [No Abstract]   [Full Text] [Related]  

  • 60. H-2 antigens on a murine lymphoma are associated with additional proteins.
    Callahan GN; Allison JP
    Nature; 1978 Jan; 271(5641):165-7. PubMed ID: 74802
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.